Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Covid-19 got us involved in other studies since pretty much everything else shut down in all of 2020."
Obviously the first half of that is true.

5 days after the Company announced "that preliminary top-line data from its Phase 1 trial (NCT03234465) studying the use of delayed-release tablets of Brilacidin showed the trial met its primary endpoints" they ran a PR entitled "Innovation Pharmaceuticals Exploring Lead Defensin Mimetic Drug Candidate Brilacidin as Potential Novel Coronavirus Treatment" and it was o f f _ t o _ t h e _ r a c e s.

The Oralogik pill trial was over. Secondary outcomes weren't reported as far as I could tell. Hot off the presses the presentation says that B is "currently being developed as an oral tablet in ulcerative colitis(UC), Phase 2 planning underway".
The latest IPIX filing says "Our oral program development will be supported by a modified release oral capsule formulation now in development."

A tablet is not a capsule.
If Phase 2 planning is underway then "everything else (isn't) shut down".
I simply asked what happened to the Oralogik pill. Did the secondary outcomes reveal issues?

Silly questions?